[ad_1] Novartis management has achieved the positive results they have been expecting from Entresto's PIONEER-HF study to confirm accelerated sales of heart medicines. Initially slow, prevented by reluctant doctors from adopting a …
Read More »Novartis builds a blockbuster for Entresto, beating a cheap ECA inhibitor – or not – Endpoints News
